The Trump administration’s cancellation of $766 million in contracts to develop mRNA vaccines against potential pandemic flu ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

U.S. Health Secretary Robert F. Kennedy Jr. has championed "medical freedom" while simultaneously limiting access to COVID-19 ...

On May 28, the U.S. Department of Health and Human Services (HHS) canceled a $590 million contract to Moderna, a ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

Pediatric infectious disease expert Dr. Lakshmi Panagiotakopoulos resigned on Tuesday as co-leader of a U.S. CDC working ...

Despite positive results from a Phase I/II trial of its investigational pandemic influenza vaccine, mRNA-1018, Moderna’s ...

HHS has ended a government-funded program that distributed free COVID-19 tests to community organizations, a department ...

In this week’s edition of InnovationRx, we look at the impact of Trump’s proposed budget cuts on biomedical research and ...

Merck held talks over a potential $3 billion acquisition of MoonLake Immunotherapeutics, as it seeks to replenish its drug pipeline ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...